Dr. Vincent Ma
Claim this profileUniversity of Wisconsin Carbone Cancer Center
Area of expertise
Skin Cancer
Vincent Ma has run 5 trials for Skin Cancer. Some of their research focus areas include:
Melanoma
Vincent Ma has run 4 trials for Melanoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Wisconsin - Carbone Cancer Center
University Of Wisconsin Carbone Cancer Center - University Hospital
Clinical Trials Vincent Ma is currently running
IPH5201 + Durvalumab + Chemotherapy
for Lung Cancer
In Cohort 1, the study was intended to assess safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab, in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC). Study Design was updated following the results of interim analysis # 2 (protocol amendment, adding cohort 2). Cohort 2 includes patients with resectable Stage II to IIIB NSCLC expressing PD-L1 ≥1%, receiving (only) neoadjuvant IPH5201+ durvalumab + chemotherapy
Recruiting
1 award
Phase 2
11 criteria
Encorafenib/Binimetinib/Nivolumab vs Ipilimumab/Nivolumab
for Melanoma
This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Ipilimumab and nivolumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread. This trial aims to find out which approach is more effective in shrinking and controlling brain metastases from melanoma.
Recruiting
1 award
Phase 2
23 criteria
More about Vincent Ma
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Vincent Ma has experience with
- Pembrolizumab
- Durvalumab
- IPH5201
- Standard Chemotherapy
- Carboplatin
- SEA-CD40
Breakdown of trials Vincent Ma has run
Skin Cancer
Melanoma
Non-Small Cell Lung Cancer
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vincent Ma specialize in?
Vincent Ma focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Vincent Ma currently recruiting for clinical trials?
Yes, Vincent Ma is currently recruiting for 3 clinical trials in Madison Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Vincent Ma has studied deeply?
Yes, Vincent Ma has studied treatments such as Pembrolizumab, Durvalumab, IPH5201.
What is the best way to schedule an appointment with Vincent Ma?
Apply for one of the trials that Vincent Ma is conducting.
What is the office address of Vincent Ma?
The office of Vincent Ma is located at: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin 53792 United States. This is the address for their practice at the University of Wisconsin Carbone Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.